MyFinsight
Home
Blog
About
Cash and cash
equivalents
$24,192K
Inventory
$21,472K
Accounts receivable, net
$14,482K
Prepaid expenses and
other current assets
$2,842K
Restricted cash
$368K
2031 and thereafter
$19,495K
2027
$4,179K
2028
$3,970K
2029
$3,823K
2030
$3,822K
2026 (july 1 -
december 31)
$2,108K
Total current assets
$63,356K
(7599.58%↑ Y/Y)
Intangible assets, net
$37,397K
Goodwill
$24,681K
Property and equipment,
net
$8,881K
Operating lease
right-of-use assets, net
$3,041K
Total assets
$137,356K
(16592.71%↑ Y/Y)
Accumulated deficit
-$113,284K
(-321.26%↓ Y/Y)
Total liabilities and
stockholders' equity
$137,356K
(16592.71%↑ Y/Y)
Total stockholders'
(deficit) equity
-$1,501K
(76.89%↑ Y/Y)
Additional paid in capital
$109,705K
(437.84%↑ Y/Y)
Accumulated other
comprehensive income
$2,078K
Total liabilities
$138,857K
(1797.69%↑ Y/Y)
Convertible notes payable -
related party
$43,321K
Venture loan and
security agreement, net
$26,593K
Accrued expenses
$20,745K
(87668.66%↑ Y/Y)
Other long-term
liabilities-Nonrelated Party
$20,406K
Other long-term
liabilities-Related Party
$12,935K
Accounts payable
$5,853K
Operating lease
liabilities, net of current...
$2,550K
Other
liabilities-Nonrelated Party
$1,527K
Other
liabilities-Related Party
$1,460K
Deferred revenue, net of
current portion
$1,093K
Contingent consideration
$1,000K
Deferred revenue,
current portion
$729K
Operating lease
liabilities, current portion
$645K
Back
Back
Balance Sheet
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS)
source: myfinsight.com